image
Healthcare - Medical - Healthcare Information Services - NYSE - US
$ 52.39
2.24 %
$ 9.83 B
Market Cap
52.39
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one DOCS stock under the worst case scenario is HIDDEN Compared to the current market price of 52.4 USD, Doximity, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one DOCS stock under the base case scenario is HIDDEN Compared to the current market price of 52.4 USD, Doximity, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one DOCS stock under the best case scenario is HIDDEN Compared to the current market price of 52.4 USD, Doximity, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart DOCS

image
$85.0$85.0$80.0$80.0$75.0$75.0$70.0$70.0$65.0$65.0$60.0$60.0$55.0$55.0$50.0$50.0$45.0$45.0$40.0$40.015 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
475 M REVENUE
13.45%
164 M OPERATING INCOME
30.99%
148 M NET INCOME
30.81%
184 M OPERATING CASH FLOW
2.50%
31.2 M INVESTING CASH FLOW
152.04%
-277 M FINANCING CASH FLOW
-271.37%
169 M REVENUE
23.22%
79.9 M OPERATING INCOME
50.40%
75.2 M NET INCOME
70.30%
65.2 M OPERATING CASH FLOW
-4.62%
-58.9 M INVESTING CASH FLOW
-243.91%
-25.2 M FINANCING CASH FLOW
-28.15%
Balance Sheet Doximity, Inc.
image
Current Assets 913 M
Cash & Short-Term Investments 763 M
Receivables 101 M
Other Current Assets 48.7 M
Non-Current Assets 166 M
Long-Term Investments 0
PP&E 24.6 M
Other Non-Current Assets 142 M
70.68 %9.39 %4.51 %13.14 %Total Assets$1.1b
Current Liabilities 147 M
Accounts Payable 2.25 M
Short-Term Debt 2.15 M
Other Current Liabilities 143 M
Non-Current Liabilities 30.7 M
Long-Term Debt 12.4 M
Other Non-Current Liabilities 18.3 M
80.26 %6.97 %10.30 %Total Liabilities$178.0m
EFFICIENCY
Earnings Waterfall Doximity, Inc.
image
Revenue 475 M
Cost Of Revenue 50.7 M
Gross Profit 425 M
Operating Expenses 261 M
Operating Income 164 M
Other Expenses 16.3 M
Net Income 148 M
500m500m450m450m400m400m350m350m300m300m250m250m200m200m150m150m100m100m50m50m00475m(51m)425m(261m)164m(16m)148mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
89.34% GROSS MARGIN
89.34%
34.47% OPERATING MARGIN
34.47%
31.04% NET MARGIN
31.04%
16.37% ROE
16.37%
13.67% ROA
13.67%
13.98% ROIC
13.98%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Doximity, Inc.
image
180m180m160m160m140m140m120m120m100m100m80m80m60m60m40m40m20m20m002020202020212021202220222023202320242024
Net Income 148 M
Depreciation & Amortization 10.3 M
Capital Expenditures -5.8 M
Stock-Based Compensation 51.1 M
Change in Working Capital -24.5 M
Others -28.6 M
Free Cash Flow 178 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Doximity, Inc.
image
Wall Street analysts predict an average 1-year price target for DOCS of $45.9 , with forecasts ranging from a low of $25 to a high of $70 .
DOCS Lowest Price Target Wall Street Target
25 USD -52.28%
DOCS Average Price Target Wall Street Target
45.9 USD -12.32%
DOCS Highest Price Target Wall Street Target
70 USD 33.61%
Price
Max Price Target
Min Price Target
Average Price Target
90908080707060605050404030302020May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 11
6. Ownership
Insider Ownership Doximity, Inc.
image
Sold
0-3 MONTHS
88 M USD 6
3-6 MONTHS
6.79 M USD 3
6-9 MONTHS
3.67 M USD 4
9-12 MONTHS
1.44 M USD 4
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
5 Momentum Stocks to Buy for April Despite a Disappointing March Five stocks have strong momentum for April. These are: APP, MRVL, DOCS, RDDT, VEEV. zacks.com - 2 weeks ago
Doximity (DOCS) Falls More Steeply Than Broader Market: What Investors Need to Know Doximity (DOCS) closed at $60.55 in the latest trading session, marking a -1.51% move from the prior day. zacks.com - 3 weeks ago
3 Medical Services Industry Stocks to Buy as AI Fuels Growth The Zacks Medical - Services industry is undergoing a transformation on massive artificial intelligence adoption. COR, DOCS and MD are set to gain the most. zacks.com - 3 weeks ago
Doximity (DOCS) Beats Stock Market Upswing: What Investors Need to Know The latest trading day saw Doximity (DOCS) settling at $62.99, representing a +0.35% change from its previous close. zacks.com - 4 weeks ago
Spotify, Rubrik Lead Five Growth Stocks Regaining This Key Level Amid the market correction, few growth stocks are above their 50-day moving averages. Spotify, Rubrik lead five that have reclaimed that level. investors.com - 1 month ago
Buy These 5 Top-Ranked Stocks to Play Likely Earnings Beat Top-ranked stocks Doximity (DOCS), Life Time Group Holdings (LTH), Adtalem Global Education (ATGE), BioMarin Pharmaceutical (BMRN) and Iridium Communications (IRDM) are likely to beat on the bottom line in their upcoming releases. zacks.com - 1 month ago
Buy 5 High-Flying Health & Fitness Stocks Year to Date With More Upside Five Health & Fitness stocks have strong growth potential for 2025. These are: GRMN, SFM, DOCS, LTH, VFC. zacks.com - 1 month ago
Is Doximity (DOCS) a Solid Growth Stock? 3 Reasons to Think "Yes" Doximity (DOCS) possesses solid growth attributes, which could help it handily outperform the market. zacks.com - 1 month ago
5 Top-Ranked Stocks Poised for an Earnings Beat Top-ranked stocks Tenet Healthcare (THC), Fortinet (FTNT), Lyft (LYFT), Garmin (GRMN) and Doximity (DOCS) are likely to beat on the bottom line in their upcoming releases. zacks.com - 1 month ago
Market Shift: These 3 Stocks Are Winning While Big Tech Lags As earnings season winds down, a notable trend has emerged in the markets: several mega-cap stocks have underperformed year-to-date (YTD). In contrast, several mid-to-large cap stocks with strong retail followings have delivered superior returns. marketbeat.com - 1 month ago
DOXIMITY INVESTOR REMINDER: Scott+Scott Attorneys at Law LLP Investigates Doximity, Inc.'s Directors and Officers for Breach of Fiduciary Duties – DOCS NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the leadership of Doximity, Inc. (“Doximity”) (NYSE: DOCS) breached their fiduciary duties to Doximity and its shareholders. CLICK HERE TO LEARN MORE Scott+Scott is investigating whether members of Doximity's board of directors or senior management failed to manage Doximity in an acceptable manner, in breach of their fiduciary dut. businesswire.com - 1 month ago
Doximity: Rating Downgrade As Near-Term Upside Is Priced In I downgraded Doximity from buy to hold due to expected growth slowdown and current high valuation at 40.5x forward EBITDA. DOCS reported strong Q3 performance with $168.6 million revenue, 25% y/y growth, and 93.3% gross margin, driven by high pharma client demand. New ad products grew over 100% y/y, now contributing >20% of pharma revenue, showing strong underlying demand and expanding advertiser engagement. seekingalpha.com - 2 months ago
8. Profile Summary

Doximity, Inc. DOCS

image
COUNTRY US
INDUSTRY Medical - Healthcare Information Services
MARKET CAP $ 9.83 B
Dividend Yield 0.00%
Description Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Contact 500, 3rd Street, San Francisco, CA, 94107 https://www.doximity.com
IPO Date June 24, 2021
Employees 827
Officers Ms. Jennifer W. Chaloemtiarana J.D. General Counsel & Corporate Secretary Mr. Joel Davis Senior Vice President of Product Ms. Shari Buck Co-founder and SVice President People & Ops Mr. Perry Scott Gold Head of Investor Relations Mr. Bruno Miranda Senior Vice President of Engineering Ms. Anna Bryson Chief Financial Officer Dr. Nate Gross M.D. Co-Founder & Chief Strategy Officer Mr. Craig A. Overpeck Senior Vice President of Commercial Operations Mr. Jey Balachandran Chief Technology Officer Mr. Jeffrey A. Tangney Co-Founder, Chief Executive Officer & Chairperson